Oral Wegovy Pill: No More Injections for Weight Loss?
Last updated: 4 June 2026 | Medically reviewed content — always consult your doctor
For millions of people who want the weight loss benefits of Wegovy but hate needles, January 2026 brought game-changing news: the oral Wegovy pill was FDA-approved in the United States, becoming the first GLP-1 weight loss tablet on the market.
Same active ingredient (semaglutide). Same powerful results. No injection required. In clinical trials, the Wegovy pill delivered 14–17% body weight loss over 64 weeks — matching the injectable version that has already transformed the weight loss landscape.
Here's everything South Africans need to know about the oral Wegovy pill: how it works, what the clinical data shows, how it compares to the injection, when it might reach SA, and what it could cost in rands.
What Is the Oral Wegovy Pill?
The oral Wegovy pill is a once-daily tablet containing semaglutide — the same GLP-1 receptor agonist found in injectable Wegovy and Ozempic. Novo Nordisk developed a special formulation that protects the semaglutide peptide from being destroyed by stomach acid, allowing it to be absorbed through the stomach lining.
The approved dose for weight loss is 25mg taken once daily. For context, injectable Wegovy delivers 2.4mg once weekly — the oral dose is higher because only a small fraction of the tablet's semaglutide is absorbed through the stomach.
How Does It Work?
Like all semaglutide products, the Wegovy pill works by mimicking the GLP-1 hormone your body naturally produces after eating:
- Reduces appetite — acts on brain centres that control hunger, making you feel full faster and for longer
- Slows gastric emptying — food stays in your stomach longer, reducing the urge to eat again
- Improves insulin response — helps regulate blood sugar, reducing cravings and energy crashes
- Reduces food reward — decreases the pleasure response to high-calorie foods, making it easier to resist overeating
The difference is simply the delivery method: a daily pill instead of a weekly injection. The end result in your body is the same.
Clinical Trial Results: The OASIS Programme
The oral Wegovy pill was tested in Novo Nordisk's extensive OASIS clinical trial programme, which enrolled thousands of participants across multiple countries. Here are the headline results:
OASIS 4 — The Pivotal Weight Loss Trial (25mg Dose)
This was the trial that led directly to FDA approval. It enrolled 307 adults with obesity or overweight plus at least one weight-related condition (excluding diabetes).
| Outcome | Oral Wegovy 25mg | Placebo |
|---|---|---|
| Average weight loss (all participants) | 13.6% | 2.4% |
| Average weight loss (on-treatment) | 16.6% | 2.7% |
| Achieved ≥10% weight loss | ~60% | <10% |
| Achieved ≥20% weight loss | ~30% | <3% |
| Trial duration | 64 weeks | |
OASIS 1 — The Higher Dose Trial (50mg)
An earlier trial tested the 50mg dose in adults with overweight or obesity:
- 15.1% weight loss from baseline (12.7 percentage points more than placebo)
- Results comparable to injectable Wegovy's STEP 1 trial (12.4 percentage points more than placebo)
- This confirmed that oral semaglutide could match injectable efficacy
OASIS 2 — East Asian Population (50mg)
- 14.3% weight loss with oral semaglutide 50mg vs 1.3% with placebo
- Confirmed efficacy across different ethnic populations
- Discontinuation rate of only 4.5% — good tolerability
Oral Wegovy Pill vs Injectable Wegovy: Head-to-Head Comparison
This is the question every South African considering Wegovy wants answered: should you wait for the pill, or start with the injection?
| Feature | Oral Wegovy Pill | Injectable Wegovy |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Dose | 25mg daily | 2.4mg weekly |
| How taken | Daily pill, empty stomach | Weekly injection (pen) |
| Average weight loss | 13–15% | ~15% |
| Food timing | 30-min fast after taking | No restrictions |
| Storage | Room temperature | Refrigerated (before first use) |
| Needles | None | Yes (auto-injector pen) |
| US price (2026) | ~$299/month (R5,400) | ~$349/month (R6,300) |
| SA availability | Not yet (est. 2027-2028) | Available now (~R3,700/month) |
Who Might Prefer the Pill?
- Needle-phobic individuals — the biggest advantage, eliminating injection anxiety entirely
- Travellers — no need for cold storage, sharps disposal, or carrying injection supplies through airports
- Privacy-conscious users — taking a daily tablet is less conspicuous than self-injecting
- People who dislike the injection site reactions (redness, swelling) that some users experience
Who Might Prefer the Injection?
- People with busy mornings — the weekly injection has no food timing restrictions, while the pill requires strict morning fasting
- Those who struggle with daily compliance — remembering one injection per week is easier than a pill every morning
- Users wanting proven cardiovascular data — the injectable has more long-term outcome data from the SELECT trial
How to Take the Oral Wegovy Pill
The Wegovy pill has specific dosing instructions that must be followed carefully for it to work properly:
- Take it first thing in the morning on a completely empty stomach
- Swallow whole with no more than 120ml of plain water (about half a glass)
- Do not crush, chew, or split the tablet
- Wait at least 30 minutes before eating, drinking anything else, or taking other medications
- After the 30-minute window, eat normally — enjoy your morning rooibos tea and breakfast
Dosing Schedule
Like injectable Wegovy, the oral version uses a gradual dose escalation to minimise side effects:
| Phase | Dose | Duration |
|---|---|---|
| Starting dose | 1.5mg daily | 4 weeks |
| Escalation 1 | 3.5mg daily | 4 weeks |
| Escalation 2 | 7mg daily | 4 weeks |
| Escalation 3 | 14mg daily | 4 weeks |
| Maintenance dose | 25mg daily | Ongoing |
Side Effects of the Oral Wegovy Pill
The side effect profile is similar to injectable semaglutide, with gastrointestinal symptoms being the most common, particularly during dose escalation:
| Side Effect | Oral Wegovy | Placebo |
|---|---|---|
| Any GI side effect | 74% | 42% |
| Nausea | ~45% | ~15% |
| Vomiting | ~31% | ~6% |
| Diarrhoea | ~25% | ~12% |
| Constipation | ~15% | ~8% |
| Decreased appetite | ~20% | ~5% |
| Serious adverse events | 3.9% | 8.8% |
To minimise side effects, follow the gradual dose escalation schedule and consider these practical tips:
- Eat smaller, more frequent meals rather than large portions
- Avoid fatty, greasy, or heavy foods — especially during the first few weeks at each new dose
- Stay hydrated throughout the day (just not when taking the tablet)
- Keep a food diary to identify personal trigger foods
- Try bland, easy-to-digest foods like rice, toast, or boiled chicken if nausea strikes
How Does the Wegovy Pill Compare to Other Oral Weight Loss Medications?
The oral Wegovy pill is not the only weight loss pill on the horizon. Here's how it stacks up against the competition:
| Drug | Company | Type | Weight Loss | Status (June 2026) |
|---|---|---|---|---|
| Oral Wegovy (semaglutide 25mg) | Novo Nordisk | GLP-1 agonist | 14–17% | FDA approved (Jan 2026) |
| Orforglipron (Foundayo) | Eli Lilly | GLP-1 agonist (small molecule) | ~11% | FDA approved (Apr 2026) |
| Amycretin | Novo Nordisk | GLP-1/amylin dual agonist | ~13% (Phase 1) | Phase 2 trials |
| Danuglipron | Pfizer | GLP-1 agonist (small molecule) | 8–13% | Discontinued (liver safety signal) |
When Will the Oral Wegovy Pill Be Available in South Africa?
As of June 2026, the oral Wegovy pill is not yet available in South Africa. Here's the current timeline:
| Milestone | Status |
|---|---|
| FDA approval (USA) | Approved — January 2026 |
| US commercial launch | Available — early 2026 |
| EMA submission (Europe) | Under review |
| Rybelsus (oral semaglutide for diabetes) SA registration | Registered by SAHPRA (2024) but not launched |
| Injectable Wegovy SA availability | Available — up to R3,700/month |
| Oral Wegovy SAHPRA submission | Not announced |
| Estimated SA availability | 2027–2028 (estimated) |
What South Africans Can Do Right Now
While waiting for the oral Wegovy pill:
- Injectable Wegovy is already available in SA through private healthcare providers and some medical aid schemes
- Ozempic (injectable semaglutide, lower dose) is available and sometimes prescribed off-label for weight management
- Mounjaro (tirzepatide) is another injectable option now available in SA
- Section 21 access — in exceptional cases, your doctor can apply to SAHPRA for access to unregistered medicines, though this is typically reserved for serious medical need
- Check with Dis-Chem or Clicks pharmacy for the latest availability of injectable options
- Ask your medical aid about coverage for GLP-1 medications
Estimated South African Pricing
While there's no confirmed SA pricing for the oral Wegovy pill, we can make informed estimates based on US pricing and existing SA pricing for related products:
| Product | US Price (2026) | SA Price / Estimate |
|---|---|---|
| Oral Wegovy pill (25mg daily) | ~$299/month | R4,000–R6,000/month (est.) |
| Injectable Wegovy (2.4mg weekly) | ~$349/month | Up to R3,700/month |
| Ozempic (1mg weekly) | ~$950/month | R2,500–R3,500/month |
| Mounjaro (15mg weekly) | ~$1,060/month | R3,500–R5,000/month |
Should You Wait for the Pill or Start Injections Now?
This is a very personal decision that depends on your circumstances. Here's a framework to help you decide:
Consider starting injectable Wegovy now if:
- You have a BMI of 30+ (or 27+ with comorbidities) and your health can't wait 1-2 years
- You're comfortable with once-weekly injections
- Your medical aid covers injectable Wegovy
- You want the most established treatment with the longest safety track record
Consider waiting for the pill if:
- You have severe needle phobia that genuinely prevents you from using injectable options
- Your weight situation is not medically urgent
- You're already making progress with intermittent fasting, high-protein diets, and exercise
The Bigger Picture: Oral GLP-1s Are Just the Beginning
The oral Wegovy pill represents a turning point in weight loss medicine. For the first time, the most effective class of weight loss drugs is available without injections. But the pipeline doesn't stop here:
- Next-generation oral drugs targeting multiple receptors (GLP-1 + GIP, GLP-1 + glucagon, GLP-1 + amylin) are in development
- Orforglipron (Eli Lilly) offers a small-molecule approach with no food timing restrictions
- Amycretin (Novo Nordisk) combines GLP-1 and amylin in one oral tablet
- CagriSema and retatrutide are pushing injectable weight loss beyond 20–25%
- Maritide (Amgen) offers once-monthly dosing for maximum convenience
The future of weight management in South Africa is moving rapidly from weekly injections to daily pills — and eventually to even more convenient options. The key is working with your doctor to find the approach that fits your lifestyle, budget, and health needs.
Stay Updated on Weight Loss Medications in South Africa
New weight loss drugs are reaching SA faster than ever. Bookmark this page for updates on the oral Wegovy pill's SA availability, or explore our guides to medications available right now:
Wegovy (Injectable) | Ozempic | Mounjaro | Wegovy vs Mounjaro | All Weight Loss Injections